ESMO 2025 Top 10 Must See Breast Cancer Abstracts Breast Cancer 3 Mins Read The ESMO 2025 Congress, held October 17-21 in Berlin, will feature exciting breast cancer trials that could improve patient care.…
Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials) ASBrS 4 Mins Read What Are CDK4/6 Inhibitors? CDK4/6 inhibitors, such as abemaciclib and ribociclib, are changing breast cancer treatment for HR+/HER2- early-stage patients.…
HR+/HER2- MBC 2L Outcomes: Top 10 ASCO 2025 Breakthroughs ASCO 5 Mins Read Welcome to this comprehensive web companion for the OncologyTube.com video, “HR+/HER2- metastatic breast cancer 2L outcomes: Top 10 from ASCO…
